Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Protech Home Medical submits application to list on Nasdaq » 08:19
01/13/21
01/13
08:19
01/13/21
08:19
PTQQF

Protech Home Medical

$0.00 /

+ (+0.00%)

Protech Home Medical is…

Protech Home Medical is pleased to announced that it has applied to list its common shares on the NASDAQ Capital Market. In advance of a potential listing on the NASDAQ, Protech will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission. The listing of the Company's common shares on the NASDAQ remains subject to the approval of the NASDAQ and the satisfaction of all applicable listing and regulatory requirements. While the Company intends to satisfy all of the applicable listing criteria, no assurance can be given that its application will be approved. During the NASDAQ review process, and in the event of listing on NASDAQ, the Company's common shares will continue to trade in Canada on the TSX Venture Exchange under its symbol "PTQ".

ShowHide Related Items >><<
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

07/06/20 Canaccord
Protech Home Medical initiated with a Buy at Canaccord
05/21/20
Protech Home Medical initiated with a Buy at Dougherty
04/29/20 Industrial Alliance
Protech Home Medical initiated with a Buy at Industrial Alliance
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

Conference/Events
SNN Network to hold a virtual event » 04:55
01/07/21
01/07
04:55
01/07/21
04:55
CTSDF

Converge Technology

$0.00 /

+ (+0.00%)

, CYPXF

EQ Inc

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.09 /

-0.18 (-3.42%)

, LXXGF

Lexagene Holdings

$0.00 /

+ (+0.00%)

, MCLDF

mCloud Technologies

$0.00 /

+ (+0.00%)

, NWVCF

EnWave

$0.00 /

+ (+0.00%)

, RILY

B. Riley Financial

$45.84 /

+2.51 (+5.79%)

, THBRF

Thunderbird Entertainment

$0.00 /

+ (+0.00%)

, VRNDF

Delta 9 Cannabis

$0.00 /

+ (+0.00%)

, VYGVF

Voyager Digital

$0.00 /

+ (+0.00%)

SNN Network Canada…

SNN Network Canada Virtual Event to be held on January 6-7.Webcast Link

ShowHide Related Items >><<
VYGVF Voyager Digital
$0.00 /

+ (+0.00%)

VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

RILY B. Riley Financial
$45.84 /

+2.51 (+5.79%)

NWVCF EnWave
$0.00 /

+ (+0.00%)

LXXGF Lexagene Holdings
$0.00 /

+ (+0.00%)

EQ Equillium
$5.09 /

-0.18 (-3.42%)

CTSDF Converge Technology
$0.00 /

+ (+0.00%)

12/08/20 Raymond James
Converge Technology price target raised to C$4.75 from C$3.75 at Raymond James
10/05/20 Raymond James
Converge Technology price target raised to C$3.50 from C$2.80 at Raymond James
09/10/20 Raymond James
Converge Technology price target raised to C$2.80 from C$2.35 at Raymond James
04/29/20 Raymond James
Converge Technology initiated with an Outperform at Raymond James
CYPXF EQ Inc
$0.00 /

+ (+0.00%)

09/17/20 Canaccord
EQ Inc initiated with a Speculative Buy at Canaccord
EQ Equillium
$5.09 /

-0.18 (-3.42%)

11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
07/10/20 Stifel
Equillium transferred with Buy rating, $10 target at Stifel
LXXGF Lexagene Holdings
$0.00 /

+ (+0.00%)

06/17/20 Brookline
Lexagene Holdings initiated with a Buy at Brookline
04/28/20 Industrial Alliance
Lexagene Holdings initiated with a Speculative Buy at Industrial Alliance
MCLDF mCloud Technologies
$0.00 /

+ (+0.00%)

07/15/20 Alliance Global Partners
mCloud Technologies initiated with a Buy at Alliance Global Partners
NWVCF EnWave
$0.00 /

+ (+0.00%)

12/14/20 Raymond James
EnWave price target raised to C$1.60 from C$1.20 at Raymond James
04/24/20 Raymond James
EnWave downgraded to Market Perform from Outperform at Raymond James
RILY B. Riley Financial
$45.84 /

+2.51 (+5.79%)

THBRF Thunderbird Entertainment
$0.00 /

+ (+0.00%)

10/16/20 Canaccord
Thunderbird price target raised to C$3.25 from C$2.50 at Canaccord
VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

05/20/20 Canaccord
Delta 9 Cannabis upgraded to Speculative Buy from Hold at Canaccord
VYGVF Voyager Digital
$0.00 /

+ (+0.00%)

12/17/20 Stifel
Stifel GMP starts Voyager Digital at Speculative Buy with C$3.30 price target
12/16/20 Stifel
Voyager Digital initiated with a Speculative Buy at Stifel
02/10/20 Benchmark
Voyager Digital initiated with a Speculative Buy at Benchmark
NWVCF EnWave
$0.00 /

+ (+0.00%)

EQ Equillium
$5.09 /

-0.18 (-3.42%)

  • 14
    Aug
VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

RILY B. Riley Financial
$45.84 /

+2.51 (+5.79%)

EQ Equillium
$5.09 /

-0.18 (-3.42%)

Conference/Events
SNN Network to hold a virtual event » 09:45
01/06/21
01/06
09:45
01/06/21
09:45
CTSDF

Converge Technology

$0.00 /

+ (+0.00%)

, CYPXF

EQ Inc

$0.00 /

+ (+0.00%)

, EQ

Equillium

$5.29 /

+0.02 (+0.38%)

, LXXGF

Lexagene Holdings

$0.00 /

+ (+0.00%)

, MCLDF

mCloud Technologies

$0.00 /

+ (+0.00%)

, NWVCF

EnWave

$0.00 /

+ (+0.00%)

, RILY

B. Riley Financial

$43.34 /

+0.01 (+0.02%)

, THBRF

Thunderbird Entertainment

$0.00 /

+ (+0.00%)

, VRNDF

Delta 9 Cannabis

$0.00 /

+ (+0.00%)

, VYGVF

Voyager Digital

$0.00 /

+ (+0.00%)

SNN Network Canada…

SNN Network Canada Virtual Event to be held on January 6-7.Webcast Link

ShowHide Related Items >><<
VYGVF Voyager Digital
$0.00 /

+ (+0.00%)

VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

RILY B. Riley Financial
$43.34 /

+0.01 (+0.02%)

NWVCF EnWave
$0.00 /

+ (+0.00%)

LXXGF Lexagene Holdings
$0.00 /

+ (+0.00%)

EQ Equillium
$5.29 /

+0.02 (+0.38%)

CTSDF Converge Technology
$0.00 /

+ (+0.00%)

12/08/20 Raymond James
Converge Technology price target raised to C$4.75 from C$3.75 at Raymond James
10/05/20 Raymond James
Converge Technology price target raised to C$3.50 from C$2.80 at Raymond James
09/10/20 Raymond James
Converge Technology price target raised to C$2.80 from C$2.35 at Raymond James
04/29/20 Raymond James
Converge Technology initiated with an Outperform at Raymond James
CYPXF EQ Inc
$0.00 /

+ (+0.00%)

09/17/20 Canaccord
EQ Inc initiated with a Speculative Buy at Canaccord
EQ Equillium
$5.29 /

+0.02 (+0.38%)

11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
07/10/20 Stifel
Equillium transferred with Buy rating, $10 target at Stifel
LXXGF Lexagene Holdings
$0.00 /

+ (+0.00%)

06/17/20 Brookline
Lexagene Holdings initiated with a Buy at Brookline
04/28/20 Industrial Alliance
Lexagene Holdings initiated with a Speculative Buy at Industrial Alliance
MCLDF mCloud Technologies
$0.00 /

+ (+0.00%)

07/15/20 Alliance Global Partners
mCloud Technologies initiated with a Buy at Alliance Global Partners
NWVCF EnWave
$0.00 /

+ (+0.00%)

12/14/20 Raymond James
EnWave price target raised to C$1.60 from C$1.20 at Raymond James
04/24/20 Raymond James
EnWave downgraded to Market Perform from Outperform at Raymond James
RILY B. Riley Financial
$43.34 /

+0.01 (+0.02%)

THBRF Thunderbird Entertainment
$0.00 /

+ (+0.00%)

10/16/20 Canaccord
Thunderbird price target raised to C$3.25 from C$2.50 at Canaccord
VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

05/20/20 Canaccord
Delta 9 Cannabis upgraded to Speculative Buy from Hold at Canaccord
VYGVF Voyager Digital
$0.00 /

+ (+0.00%)

12/17/20 Stifel
Stifel GMP starts Voyager Digital at Speculative Buy with C$3.30 price target
12/16/20 Stifel
Voyager Digital initiated with a Speculative Buy at Stifel
02/10/20 Benchmark
Voyager Digital initiated with a Speculative Buy at Benchmark
NWVCF EnWave
$0.00 /

+ (+0.00%)

EQ Equillium
$5.29 /

+0.02 (+0.38%)

  • 14
    Aug
VRNDF Delta 9 Cannabis
$0.00 /

+ (+0.00%)

RILY B. Riley Financial
$43.34 /

+0.01 (+0.02%)

EQ Equillium
$5.29 /

+0.02 (+0.38%)

Hot Stocks
Protech Home Medical enters LOI to acquire respiratory care company » 08:25
01/05/21
01/05
08:25
01/05/21
08:25
PTQQF

Protech Home Medical

$0.00 /

+ (+0.00%)

Protech Home Medical…

Protech Home Medical announced it has executed a non-binding letter of intent to acquire a private respiratory care company in the Southern United States reporting unaudited trailing 12-month annual revenues of approximately $7M, positive adjusted EBITDA, and positive net income. The target company has been a leader in the respiratory home care services industry within the area it operates in the Southern United States for over 20 years. The target company would serve as an entry for Protech into the new Southern State, adding over 10,000 active patients and a location within 10 minutes of a major metropolitan hub. Protech would begin to build its presence in this new geography by organically leveraging its existing infrastructure and looking for additional bolt-on opportunities. The target company has a heavily weighted respiratory product mix at over 85%, possessing a large selection of respiratory and home medical equipment to meet the needs of today's patients at home. The staff delivers on a high touch service model, aligned with Protech's existing model, and is continually educating their patient base to ensure strong compliance of equipment. Moreover, the target company has a stable and diverse payor mix with no more than 50% coming from a particular payor source. In addition, the target company would give Protech the opportunity to add over 5,000 patients from its patient base to Protech's existing subscription-based resupply program and Protech expects it would derive strong revenue synergies from this initiative. The acquisition is expected to increase Protech's annual revenues by approximately $7M. Leveraging existing infrastructure, Protech expects to achieve additional revenue and EBITDA generated from organic growth, cross selling and corporate synergies. According to the LOI, Protech expects to close the acquisition for cash at a reasonable multiple that would immediately be accretive to EBITDA and net income. Closing of the acquisition is subject to final due diligence, final negotiation and execution of a definitive purchase agreement and all necessary approvals. Closing is anticipated to be within the next 30 days.

ShowHide Related Items >><<
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

07/06/20 Canaccord
Protech Home Medical initiated with a Buy at Canaccord
05/21/20
Protech Home Medical initiated with a Buy at Dougherty
04/29/20 Industrial Alliance
Protech Home Medical initiated with a Buy at Industrial Alliance
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

Over a month ago
Hot Stocks
Protech Home Medical appoints Kevin Carter to board of directors » 08:27
12/09/20
12/09
08:27
12/09/20
08:27
PTQQF

Protech Home Medical

$0.00 /

+ (+0.00%)

Protech Home Medical…

Protech Home Medical announced that Dr. Kevin Carter has joined the board of directors of the Company as an independent director. Kevin A. Carter, DO, FAASM, is Board Certified in Sleep Medicine by the American Board of Family Medicine; he is also Board Certified in Family Medicine. Before establishing his current practice, Dr. Carter served as Medical Director at the Martin Army Sleep Medicine Center at Fort Benning, Georgia. Prior to this appointment, he served as a United States Army Field Surgeon, with service including deployment in Iraq. Currently, through the Carter Sleep Center, he offers full-spectrum sleep medicine evaluations, diagnosis, and treatments.

ShowHide Related Items >><<
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

07/06/20 Canaccord
Protech Home Medical initiated with a Buy at Canaccord
05/21/20
Protech Home Medical initiated with a Buy at Dougherty
04/29/20 Industrial Alliance
Protech Home Medical initiated with a Buy at Industrial Alliance
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

Conference/Events
OTC Markets Group to hold a virtual conference » 09:09
12/03/20
12/03
09:09
12/03/20
09:09
FNNZF

FINCANNA CAPITAL

$0.00 /

+ (+0.00%)

, PTQQF

Protech Home Medical

$0.00 /

+ (+0.00%)

, THBRF

Thunderbird Entertainment

$0.00 /

+ (+0.00%)

Innovation Investor…

Innovation Investor Virtual Conference will be held on December 3. Webcast Link

ShowHide Related Items >><<
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

FNNZF FINCANNA CAPITAL
$0.00 /

+ (+0.00%)

PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

07/06/20 Canaccord
Protech Home Medical initiated with a Buy at Canaccord
05/21/20
Protech Home Medical initiated with a Buy at Dougherty
04/29/20 Industrial Alliance
Protech Home Medical initiated with a Buy at Industrial Alliance
THBRF Thunderbird Entertainment
$0.00 /

+ (+0.00%)

10/16/20 Canaccord
Thunderbird price target raised to C$3.25 from C$2.50 at Canaccord
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

Earnings
Protech Home Medical sees Q4 revenue C$26.1M-C$26.5M, consenus C$26.34M » 08:26
11/30/20
11/30
08:26
11/30/20
08:26
PTQQF

Protech Home Medical

$0.00 /

+ (+0.00%)

Protech Home Medical…

Protech Home Medical announced record preliminary financial results for the fourth quarter of 2020, ending September 30, 2020. Revenue in the range of C$26.1M to C$26.5M. The Company experienced robust organic growth in the fourth quarter, however the reported CAD revenue amount was offset by a weakening of the US dollar relative the Canadian dollar by approximately 4%. Adjusted EBITDA in the range of C$5.6M to C$6.1M. "We are extremely satisfied with the record preliminary financial performance in the fourth quarter and the foundation that has been built for continued aggressive growth in 2021 and beyond. It is the resilience of the entire team, whilst dealing with the impact of a global pandemic that allowed us to surpass our financial objectives in the fourth quarter and for the full year of 2020," commented Greg Crawford, CEO and Chairman of Protech. "We have seen our sleep business pick up in the back half of the year, approaching levels seen early in 2020, and are optimistic the sleep business will return to and surpass pre-pandemic levels in 2021. As a whole, our business remains robust into our fiscal first quarter of 2021, our M&A pipeline is full, and we are well capitalized with our pristine balance sheet to capture the significant opportunities at our front door. We are building a world class clinical respiratory organization focused on superior patient care, and I am extremely proud of the work by our team as evidenced in our strong results. Furthermore, we are proud to report there has been a surge in the usage of our tele-health platform, and we are proud to offer both remote and in-person options to our patients as it comes to the education of utilizing our equipment. We believe the need for in-home healthcare will only continue to accelerate across the country, and hospitals will continue to provide Protech with continued opportunity, and we are ready to capitalize. We felt it extremely important to continue to keep our shareholders apprised with our financial performance in real time. We look forward to sharing our full financial results and commentary in January."

ShowHide Related Items >><<
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

07/06/20 Canaccord
Protech Home Medical initiated with a Buy at Canaccord
05/21/20
Protech Home Medical initiated with a Buy at Dougherty
04/29/20 Industrial Alliance
Protech Home Medical initiated with a Buy at Industrial Alliance
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

Hot Stocks
Protech calls CMS decision to cancel competitive bidding 'appropriate' » 08:26
10/28/20
10/28
08:26
10/28/20
08:26
PTQQF

Protech Home Medical

$0.00 /

+ (+0.00%)

Protech Home Medical is…

Protech Home Medical is pleased to comment on the decision made by the Centers for Medicare and Medicaid Services, wherein the CMS has not awarded contracts for any of the product categories that would have affected Protech's revenue because the expected payment amounts did not achieve expected savings for the Competitive Bidding Program that was expected to begin on January 1, 2021. The company said, "Protech believes that in light of the COVID-19 pandemic, the decision made by the CMS was appropriate and proper given these unprecedented times. The decision will help to ensure that there are no unnecessary barriers to the quality of care for patients, such as access to home respiratory products, other needed supplies, and durable medical equipment. The Company believes that continuing the CBP program at this time could have had a negative impact on patient care that is centered around quality of service. It is evident that home-based care for the growing population of elderly Americans is crucial, and reducing the burden on hospitals, nursing homes, and other senior living facilities, will be imperative going forward. To that end, Protech is prepared and ready to respond to an acceleration of the pandemic, and like other industry participants, will continue to be focused on building capacity in the coming months, rather than preparing to cut capacity, and this CMS decision eliminates that threat. The Company believes that the decision by CMS to not award competitive bidding contracts for any of the 13 product categories for Round 2021 was also predicated on the fact that the previously competed payment amounts did not achieve the expected savings. Accordingly, the Company believes that reimbursement rates have likely neared a floor and there is no Medicare reimbursement rate cut risks for the foreseeable future. This is extremely bullish for Protech's current business as it provides the Company with a significantly clearer outlook on the margin for its product mix, such as PAP machines, nebulizers, oxygen systems, wheelchairs, hospital beds, and seat lifts, alongside non-invasive ventilators, which had been removed previously. Moreover, this assists the Company in maintaining a stable patient base, with accelerating growth as the Company continues to build market share. Protech has played a vital role in hospital discharges, serving vulnerable patients and the Company is delighted that CMS recognizes the importance of the role HME providers play."

ShowHide Related Items >><<
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

07/06/20 Canaccord
Protech Home Medical initiated with a Buy at Canaccord
05/21/20
Protech Home Medical initiated with a Buy at Dougherty
04/29/20 Industrial Alliance
Protech Home Medical initiated with a Buy at Industrial Alliance
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

Over a quarter ago
Hot Stocks
Protech Home Medical acquires Sleepwell for $9.3M in cash, $5.1M in shares » 09:00
10/26/20
10/26
09:00
10/26/20
09:00
PTQQF

Protech Home Medical

$0.00 /

+ (+0.00%)

Protech Home Medical…

Protech Home Medical announced that it has acquired Sleepwell, a company based in Georgia, reporting unaudited trailing 12-month annual revenues of approximately $13M, adjusted EBITDA of approximately $3.25M, net income of approximately $2.5M and no debt. The acquisition of Sleepwell was originally announced by Protech on September 8, 2020 when it executed a non-binding letter of intent. Excluding the impact of future acquisitions, and organic growth derived from continuing operations, the company is pleased to share the following selected financial and operating metrics for Protech following the closing of Sleepwell: Run-Rate Revenue of $120-$125M; Run-Rate Adjusted EBITDA of $26-$30M; 110,000 current active patients; 17,000 unique referrals; 48 locations across 10 U.S. States. Sleepwell is a leader in sleep services in the State of Georgia, with significant penetration in the Southeastern corridor of the region. Resembling Protech's mission, Sleepwell and its 34 employees have a keen focus on delivering superior service through patient care and education, providing high-quality equipment, and supplies. In addition to Georgia, Sleepwell also provides sleep services to patients in Dayton, Ohio, which represents a new market for Protech. The acquisition provides the Company with an attractive metro hub within the State of Ohio where it will leverage its existing first-rate infrastructure to create additional patient growth opportunities. Protech's presence in the Southeast will greatly increase with five new locations, and the addition of three new markets including Dayton, and will increase Protech's active patient count by over 15,000. Sleepwell has tremendous diversification amongst referral sources, a strong recurring revenue platform, and a very solid and diversified payor base. Sleepwell is highly concentrated on sleep therapy with a very strong re-supply business, which Protech intends to significantly expand upon. In order to accomplish this objective, Protech will utilize its technology driven, patient centric model already implemented across the entire organization to run the Sleepwell re-supply program, which the Company expects will serve to significantly reduce fulfillment errors and increases overall volumes. Protech's keen understanding and utilization of significant workflow processes has driven extraordinary operational efficiencies and will be a major contributor to accelerated growth for the future. Currently, Protech derives $25M from its re-supply subscription model and anticipates that growing to over $30 million with Sleepwell fully integrated. Protech is pleased to announce that Dave McLeod, 12-year DME veteran and owner of Sleepwell, will join the Protech executive team as Director of Sleep Services. Under the terms of the definitive purchase agreement, subject to closing and hold back adjustments, Protech has acquired Sleepwell for a combination of cash and share consideration of approximately $9.3M and $5.1M, respectively. Post integration, it is expected that Sleepwell will increase Protech's annual revenues by approximately $13 million and adjusted EBITDA by $3.4-$4.0M. Leveraging existing infrastructure and payor contracts, Protech expects to achieve additional revenue generated from organic growth, cross selling and corporate synergies. The approximate $5.1M share consideration is being issued at $1.47 per share and is payable as to 2,517,857 common shares on January 4, 2021 and up to 982,142 on August 31, 2022.

ShowHide Related Items >><<
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

07/06/20 Canaccord
Protech Home Medical initiated with a Buy at Canaccord
05/21/20
Protech Home Medical initiated with a Buy at Dougherty
04/29/20 Industrial Alliance
Protech Home Medical initiated with a Buy at Industrial Alliance
PTQQF Protech Home Medical
$0.00 /

+ (+0.00%)

Recommendations
Thunderbird price target raised to C$3.25 from C$2.50 at Canaccord » 11:21
10/16/20
10/16
11:21
10/16/20
11:21
THBRF

Thunderbird Entertainment

$0.00 /

+ (+0.00%)

Canaccord analyst…

Canaccord analyst Aravinda Galappatthige raised the firm's price target on Thunderbird Entertainment to C$3.25 from C$2.50 and keeps a Buy rating on the shares.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.